Correlation of NRAS mutations with clinical response to high-dose IL-2 in patients with advanced melanoma.
Joseph RW, Sullivan RJ, Harrell R, Stemke-Hale K, Panka D, Manoukian G, Percy A, Bassett RL, Ng CS, Radvanyi L, Hwu P, Atkins MB, Davies MA.
Joseph RW, et al.
J Immunother. 2012 Jan;35(1):66-72. doi: 10.1097/CJI.0b013e3182372636.
J Immunother. 2012.
PMID: 22130161
Free PMC article.